Eliminating stroke as a leading cause of death and disability by increasing 20x the rate of stroke treatment within the golden hour in 10 years.
Location: New Zealand
Employees: 1-10
Total raised: $17.03M
Founded date: 2019
Investors 1
| Date | Name | Website |
| 19.07.2023 | New Zealan... | nzgcp.co.n... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 29.07.2026 | Seed | $9.75M | New Zealan... |
| 11.02.2026 | Seed | $7.28M | Nuance Con... |
Mentions in press and media 5
| Date | Title | Description |
| 29.07.2026 | Wellumio Raises $9.75 Million Pre-Series A To Advance Portable Stroke Imaging Technology | Wellumio has completed an oversubscribed $9.75 million pre-Series A funding round to advance the clinical development, regulatory approval and commercialization of Axana, its portable brain imaging system for point-of-care stroke detection.... |
| 24.07.2026 | Wellumio Closes $9.75M to Commercialize Axana Portable Brain Imaging Device | What You Should Know New Zealand medical technology startup Wellumio has finalized its oversubscribed $9.75M pre-Series A funding round, adding international venture capital from Australia (Bioshore Ventures) and the United States (Jumpspac... |
| 11.02.2026 | Wellumio Raises $7.28M to Bring MRI Scans Directly to the Bedside | (L to R) Dion Thomas, Dr Shieak Tzeng, Dr Sergei Obruchkov, and Dr Paul Teal What You Should Know The Raise: New Zealand-based Wellumio has raised $7.28M in the first close of its pre-Series A round, led by Nuance Connected Capital, to fast... |
| 06.02.2025 | Stroke Detection Innovator Wellumio Enrolls First Patient in Australian Clinical Trial for 'Axana' 0.1T portable magnetic resonance imaging device (Portable MRI study) | "Revolutionary portable device leverages advanced magnetic resonance technology to rapidly detect acute stroke biomarkers, enabling frontline care teams to make faster, life-saving decisions within the critical 'golden hour." A Me... |
| 06.01.2025 | Wellumio Expands Stroke Detection Device to U.S. Market | What You Should Know: – Wellumio, a New Zealand-based medical device innovator announced the launch of a new subsidiary in California, a strategic move aimed at facilitating US-based clinical trials for its groundbreaking Axana device and a... |